Filter News
Area of Research
- (-) Neutron Science (15)
- (-) Nuclear Science and Technology (13)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (18)
- Clean Energy (17)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (9)
- Fusion Energy (7)
- Isotopes (7)
- Materials (12)
- Materials for Computing (3)
- National Security (12)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Sensors and Controls (1)
- Supercomputing (22)
News Topics
- (-) Advanced Reactors (11)
- (-) Biomedical (14)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (10)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (7)
- Biology (6)
- Biotechnology (1)
- Chemical Sciences (3)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Computer Science (15)
- Coronavirus (9)
- Cybersecurity (2)
- Decarbonization (3)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (9)
- High-Performance Computing (2)
- Isotopes (5)
- Machine Learning (3)
- Materials (14)
- Materials Science (26)
- Mathematics (1)
- Microscopy (3)
- Molten Salt (4)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (103)
- Nuclear Energy (38)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Space Exploration (8)
- Summit (6)
- Sustainable Energy (3)
- Transformational Challenge Reactor (3)
- Transportation (5)
Media Contacts
Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses.
How do you get water to float in midair? With a WAND2, of course. But it’s hardly magic. In fact, it’s a scientific device used by scientists to study matter.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A developing method to gauge the occurrence of a nuclear reactor anomaly has the potential to save millions of dollars.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.